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PROGRAMME:
2pmWelcome
2.15 to 3.1 Opm PresentedAbstracts
3.1 Opm Invited abstract:
"NICAM:theflagshipmanagedclinicalnetwork.
DrGerardDaly,ConsultantRespiratoryPhysician,
Altnagelvin Area Hospital
3.30 AfternoonTea
3.45pm Business Meeting
3.55pm to 4.45pmAbstracts
4.45pm Guest Lecture:
"Emergingtreatmentsforadvancedlungdisease".
DrJEgan, ConsultantPhysician, MaterHospital
Dublin
ABSTRACTS
ACUTE PARALYSISAND HYPOKALAEMIA IN
A CAUCASIAN MAN: A CASE OF THYROTOXIC
PERIODIC PARALYSIS
K Mullan, D Comer, SJ Hunter
Regional Centre for Endocrinology and Diabetes, Royal
Victoria Hospital, Belfast.
A37 yearold manpresentedtotheA+Edepartment
after he awoke unable to move his torso or limbs.
There were no obvious precipitating factors and no
history ofviral illness.
On admission pulse was 100 bpm, blood pressure
130/84 mmHg. He had a flaccid quadraparesis
with diminished reflexes, down-going plantars but
no sensory deficit. ECG showed a prolonged QT
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interval.Ablood gas sample showedhypokalaemia
(1.6mmol/L) with no acid-base disturbance and
normal bloodgases. He hadno history ofrecurrent
vomitingordiarrhoea,andurinarybiochemistrywas
not suggestive ofexcessive potassium loss.
Aftertreatmentwith80mmolsofiv [K] over5 hours
hismuscleweaknessresolvedbut [K] reboundedto
5.8mmol/L.Endocrineassessmentrevealedahistory
of weight loss of 16kg in the preceding months,
sweating episodes, heat intolerance, tremor and
fatigue. Examinationrevealed a fine tremor, lid lag
andamoderategoitre.Freethyroxinewas >80pmol/
L and TSH <0.0lmU/L. A diagnosis ofthyrotoxic
periodic hypokalaemic paralysis was made. He
was commenced on carbimazole and propranolol.
Serum [K] remained within normal limits and he
was discharged 4 days later with arrangements for
radioactive iodine treatment.
Thyroid periodic paralysis (TPP) is a rare but
potentiallylifethreateningcondition.Hypokalaemia
resultsfromintracellularpotassiumshifts.Potassium
treatmentshouldbecarefullymonitoredasrebound
hyperkalaemia is recognised. The mechanism of
TPP is uncertainbuthyperthyroidism is associated
with activation of the sodium-potassium pump.
The cornerstone of treatment is restoration ofthe
euthyroid state.
DISSECTINGAN UNUSUAL CAUSE OFAN ST
SEGMENT ELEVATION INFARCTION (STEMI)
PM Donnelly, JDS Higginson, D Cochrane, S McMechan
Cardiology Department. Ulster Hospital.
A 64 year old lady presented acutely with severe
central chest pain radiating to her left arm. There
was no previous cardiac history, however multiple
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risk factors for coronary disease were noted
including hypertension, hypercholesterolaemia,
positive family history and an ex-smoker of 12
years.TheECGcharacteristicsof2mmSTsegment
elevation across the antero-septal leads resulted in
a diagnosis ofacute myocardial infarction and the
administration ofthrombolytic therapy. The ECG
appearance resolved with deep T wave inversion
in the anterolateral leads. A maximum CK-MB
rise of 114 U/L was recorded. Her in-patient
coursewas complicatedby furtherchestpain and a
catheterangiogramwasperformed.Thisrevealeda
dissection ofthe left anterior descending coronary
artery (LAD). As follow on intervention was
thoughtinappropriate, a conservative management
strategy was adopted. Within the next eight weeks
this patient was re-admitted twice with ongoing
troponin negative exertional chest pain. A repeat
catheter angiogram confirmed resolution of the
LAD dissection andthepresence ofaflowlimiting
obstructioninthedistalLADatthesiteofthehealed
dissection exitpoint.
Spontaneous coronary artery dissection (SCAD)
is a rare cause of myocardial infarction. The true
incidence is unknown and most cases (>70%) are
identifiedatpostmortem. Itisthoughtthatthereare
three different groups ofpatients that present with
SCAD namely those with pre-existing coronary
disease, women inthe thirdtrimester ofpregnancy
orintheearlypostpartumperiodandanidiopathic
group.Thepresentationcanrangefromminorchest
pain to myocardial infarction or sudden cardiac
death. The pathogenesis is not fully understood
and the mechanisms that have been proposed have
resultedinconfusionastohowthesepatientsshould
betreated.Effectivemanagementdependsonseveral
factors such as the site ofthe dissection, single or
multi-vessel involvement, coronarybloodflowand
thehaemodynamicstateofthepatient.Conservative
treatment, namely low molecular weight heparin,
aspirin,betablockadeandtimeareeffectiveformost
patients. Forpatients withmulti-vessel orleftmain
stem dissection, impaired coronary blood flow or
haemodynamic instability, percutaneous coronary
intervention or coronary artery bypass surgery is
considered the treatment ofchoice.
SCAD is an unusual cause of an STEMI. This
case demonstrates the difficulties encountered in
the diagnosis and management ofcoronary artery
dissection. A greater awareness of its existence,
particularly in young females, coupled with an
early catheterisation strategy would optimise the
management ofthis condition.
ASSOCIATION OF BACEWITH LATE ONSET
ALZHEIMER'S DISEASE
A Keown, S Todd, S McIlroy, P Passmore
Department of Geriatric Medicine, The Queen's University
ofBelfast.
Background: B-site Amyloid Precursor Protein
(APP)CleavingEnzyme(BACE)istherate-limiting
step in B-amyloid (AB3) formation generating the
N-terminal ofthe AB peptide by cleavage ofAPP
Utilisingacase-controlstudydesignweinvestigated
if a polymorphism in the gene coding for BACE
was associated withrisk for late-onsetAlzheimer's
disease (AD).
Methods: DNA was extracted from a total of263
cases and 217 age and sex matched controls from
Northern Ireland (NI). Primers were designed to
amplify a single nucleotide polymorphism (SNP)
corresponding to NCBI cluster ID rs638405.
This is a synonymous change coding for valine
with either polymorphic allele. Polymerase chain
reaction(PCR)productsweresubjectedtorestriction
enzyme digestion by Mbol and separated by
polyacrylamide gel electrophoresis and visualised
by silver staining.
Results: The CC genotype was present at a higher
frequency in AD patients compared to controls
(OR 1.84, 95%CI 0.99-2.72, y-..=4.17, p=0.041).
The presence ofthe C allele was associated with
an increasedAD risk (OR 1.32, 95%CI 1.01-1.73,
x-=4.46, p=0.035).
Conclusions: ThisSNPisassociatedwithincreased
risk forAD in the NI population.
PREDICTORS OF EXCESS MORTALITYAFTER
MYOCARDIAL INFARCTION IN FEMALES.
JNeill, CG Owens, AAJAdgey
RegionalMedicalCardiologyCentre,RoyalVictoriaHospital,
Belfast, United Kingdom.
Background: Research suggests that women have
higher mortality after acute myocardial infarction
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(AMI) than men. Potential factors to explain
this disparity include delay to presentation, less
aggressiveinterventionalstrategies,andmoresevere
disease at coronary angiography in women.
Methods: Consecutivepatients(n=426)presenting
to coronary care in the Royal Victoria Hospital
betweenJan2002 andJan2004 withchestpainand
AMI (troponinT >0.09ng/ml) were recruited. The
followingwererecorded: riskfactors; delay factors
in presentation and treatment; infarct site and left
ventricularfunction;coronaryarterydisease(CAD)
extent;treatment(medical andinterventional). The
primary endpoint was 3 month mortality.
Results: Ofthe 426 patients, 30% (128/426) were
female. Mean age offemales was 71 (SD 11) and
63 (SD13) for males (p<0.001). Men and women
had similar delay factors, risk profile, infarct site,
CAD extent and frequency ofLV impairment (EF
<45%). Females received less clopidogrel (77%,
98/128 vs 87%, 258/296, p=0.008) despite more
frequent NSTEMI presentations in women (51%,
65/128 vs 41%, 121/298, p=0.05.) Women did not
undergo angiography as frequently as men (63%,
80/128vs75%,225/298,p=0.006). Greater3month
mortality in females was confirmed (15%, 19/128
vs 6%, 17/298, p=0.004.)
Predictorsof3monthmortalitybylogisticregression
were delay in presentation, CAD extent and not
receiving clopidogrel (p=0.004).
Conclusions: Females had excess three month
mortalitycomparedwithmales. Nogenderdifference
indelayfactorsorseverityofdisease wasobserved.
Women were less likely to receive clopidogrel and
to proceed to angiography and revascularization
than men. This maybe clinically appropriate given
the advanced age ofthe females.
ANAUDIT OF COMPLIANCE OF PATIENTS
ATTENDINGAN OUT-PATIENT OSTEOPOROSIS
SERVICE
CM McVeigh, M McQuilkin, C McNally, C Williams, SA
Wright, T Beringer and MB Finch
Musgrave Park Hospital, Belfast, Northern Ireland.
Background: More than one-third of women will
sustain one or more osteoporotic fractures in their
lifetime.Anti-resorptivetherapieshavebeenshown
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to considerablydecrease fracturerisk, howeverthis
may be compromised by non-compliance.
Objective: Our aim was to establish levels of
compliance with anti-resorptive therapy overan 18
month period in patients attending an out-patient
osteoporosis service.
Methods: 126 patients were recruited from both
consultant/nurse led and GP/nurse led clinics.
Patientswereidentifiedasosteoporoticorosteopenic
on DXA and prescribed appropriate treatment.
Telephone interviews were conducted at 3, 12
and 18 months. Information recorded included
knowledge of medications, adverse effects, and
overall compliance with medication.
28% of total patients were non-compliant at 3
months. 64%ofthosewhowerenon-complianthad
experiencedadverseeffectsandwerechangedtoan
alternative drug. Compliance in this group after a
further 18months was 83%.
11%oftotalpatientswerefoundtobenon-compliant
at 12 months. 71% ofthese then changedtreatment
groups and compliance after a further 18 months
was 90%.
76%ofnon-compliantpatientscitedadverseeffects
as the reason for non-compliance.
Conclusion: Themajorityofnon-compliantpatients
were identified at 3 months with adverse effects
reported as the commonest cause. Most of these
patientsprescribedotherosteoporosistreatments at
this stage then remained compliant at 18 months.
As a result we propose that our nurse specialist
carryouttelephone reviews at 3 months to improve
compliance in these patients.
IS SER9GLY POLYMORPHISM OF DOPAMINE D3
RECEPTOR RELATED TO TARDIVE DYSKINESIA?
B McGuiness
Introduction: Tardive dyskinesia (TD) is an
involuntary movement disorder. It occurs in 20-
30%ofschizophrenicpatients. Severalgroupshave
shown that a Ser9Gly DRD3 gene polymorphism
is associatedwith risk forTD where eitherthe G/G
genotype or glycine allele has conferred elevated
risk. Other studies, however, have not replicated
this finding.
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Aim: To determine ifthe presence ofthe Ser9Gly
DRD3 gene polymorphism was associated with
increased risk ofTD in schizophrenic patients.
Methodology: From 580 cases a subsample of87
individuals were analysed, including 79 trios, 6
quads and 2 quins. Blood was genotyped for the
presence ofallele 1 (Ser-9) and allele 2 (Gly-9) of
thepolymorphism.Thetransmissiondisequilibrium
testwasappliedtolookforpreferentialtransmission.
A logistic regression analysis was then carried out
on 338 singletons.
Results: 29% of patients were TD positive, 71%
TD negative. We found no significant genotypic
association of the Gly/Gly genotype with TD
(P=0.51, Fisher's exact test) nor any significant
allelic association (X_=1.39, d.f.=2, P=0.50). The
transmissiondisequilibriumtestwasnotsignificant
(P=0.84).
With regard to singletons, only age contributed
significantly to presence ofTD. (p=0.05).
Conclusion: We found no significant association
betweenDRD3genotypeandpresenceofdyskinesia.
Age was the only positive predictor ofpresence of
TD.
investigationswereperformedtoexcludeunderlying
malignancyincludingchestx-ray, CTscanofchest,
abdomen andpelvis andbreastmammography. No
abnormalities were discovered.
Two months following diagnosis this patient was
found to be profoundly anaemic (Hb 6.5g/dL) and
a subsequent OGD showed gastric antral vascular
ectasia(GAVE syndrome)whichisassociatedwith
scleroderma.Duringanadmissionforelectiverepeat
OGD acute uraemia was discovered accompanied
by marked hypertension and pruritis. Acute
sclerodermal renal crisis ensued shortly thereafter
necessitatingemergencyhaemodialysistogetherwith
regularhaemodialysis. Immunosuppressiontherapy
was initiated with caution (cyclophosphamide
orally). This was discontinued within 5 weeks due
to marked neutropenia which was felt to be drug
induced and both captopril and cyclophosphamide
were discontinued. Captopril was replaced with
alternative anti-hypertensives. Shortly afterwards
acutehypertensivecrisisarosewithfocalneurology
and widespread ischaemic changes on CT brain.
This case highlights the clinical spectrum
of scleroderma and the dilemma of medical
management in the face ofspecific complications.
A CHALLENGING CASE OF SYSTEMIC
SCLEROSIS
LJ Shiels, GK Meenagh, MB Finch
Musgrave Park Hospital.
Wereporta57yearoldwomanwhopresentedwitha4
monthhistoryofarthralgia,myalgia,anerythematous
rashovertheinnerthighsandsymptoms suggestive
of Raynaud's phenomenon. Past medical history
included well controlled hypertension (on atenolol
and bendrofluazide).
Clinically she had waxen skin on the peripheries
and dilated digital capillary loops together with a
livedo-like rash. Haematological and biochemical
profiles were initially normal. Auto-immune
screenwas also entirelynormal. Punch skinbiopsy
revealed appearances consistent with scleroderma.
Oesophageal manometry, pulmonary function
testingandechocardiographywereallnormal.There
was rapidprogression ofskintethering. Due to the
acute nature of this presentation of scleroderma
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